Completed OBSERVATIONAL NCT01699867

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

Sponsor: Diagnostic Photonics, Inc.

Interventions Optical coherence tomography

Updated 7 times since 2017 Last updated: Dec 12, 2014 Started: Dec 31, 2012 Primary completion: May 31, 2013 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer, this trial is completed. The trial is conducted by Diagnostic Photonics, Inc. and has accumulated 7 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diagnostic Photonics, Inc.
Johns Hopkins University

Data source: Diagnostic Photonics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Annapolis, United States
• Baltimore, United States